CCR8 as a Therapeutic Novel Target: Omics-Integrated Comprehensive Analysis for Systematically Prioritizing Indications
Target identification is a crucial process in drug development, aiming to identify key proteins, genes, and signal pathways involved in disease progression and their relevance in potential therapeutic interventions. While C-C chemokine receptor 8 (CCR8) has been investigated as a candidate anti-canc...
Main Authors: | Nari Kim, Mi-Hyun Kim, Junhee Pyo, Soo-Min Lee, Ji-Sung Jang, Do-Wan Lee, Kyung Won Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/11/2910 |
Similar Items
-
Chemokine Receptor-Targeted Therapies: Special Case for CCR8
by: Bernhard Moser
Published: (2022-01-01) -
Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
by: Herman D. Lim, et al.
Published: (2021-04-01) -
Research progress of CCR8 in tumor immunotherapy
by: CHEN Yifan, LI Ting, WANG Biyun
Published: (2024-03-01) -
CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation
by: Shuna Liu, et al.
Published: (2023-11-01) -
CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer
by: Danhua Xu, et al.
Published: (2023-05-01)